Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Anti-Arrhythmic Agents in the Treatment of Atrial Fibrillation.

Hassan OF, Al Suwaidi J, Salam AM.

J Atr Fibrillation. 2013 Jun 30;6(1):864. doi: 10.4022/jafib.864. eCollection 2013 Jun-Jul. Review.

2.

Ischemic Conditioning and Atrial Fibrillation: Hope for a NewTherapy?

Schmitt H, Liang BT, Pickett C.

J Atr Fibrillation. 2013 Apr 6;5(6):753. doi: 10.4022/jafib.753. eCollection 2013 Apr-May. Review.

3.

Dronedarone: Where Does it Fit in the AF Therapeutic Armamentarium?

Reiffel JA.

J Atr Fibrillation. 2013 Apr 6;5(6):752. doi: 10.4022/jafib.752. eCollection 2013 Apr-May. Review.

4.

The evolving landscape of oral anti-arrhythmic prescriptions for atrial fibrillation in England: 1998-2014.

Hayward C, Patel HC, Patel K, Di Mario C, Lyon AR, Ahsan SY, Rowland E.

Eur Heart J Cardiovasc Pharmacother. 2016 Apr;2(2):90-4. doi: 10.1093/ehjcvp/pvv048. Epub 2015 Nov 26.

5.

Management of atrial fibrillation: focus on the role of dronedarone.

Cheng JW.

Open Access Emerg Med. 2011 Sep 21;3:55-68. doi: 10.2147/OAEM.S16679. eCollection 2011. Review.

6.

Acute effects of intravenous dronedarone on electrocardiograms, hemodynamics and cardiac functions in anesthetized dogs.

Saengklub N, Limprasutr V, Sawangkoon S, Buranakarl C, Hamlin RL, Kijtawornrat A.

J Vet Med Sci. 2016 Feb;78(2):177-86. doi: 10.1292/jvms.15-0413. Epub 2015 Sep 4.

7.

Dronedarone-digoxin interaction in PALLAS: A foxglove connection?

ElMaghawry M, Farouk M.

Glob Cardiol Sci Pract. 2015 Jan 26;2015:4. doi: 10.5339/gcsp.2015.4. eCollection 2015.

8.

How does Chronic Atrial Fibrillation Influence Mortality in the Modern Treatment Era?

Sankaranarayanan R, Kirkwood G, Visweswariah R, Fox DJ.

Curr Cardiol Rev. 2015;11(3):190-8. Review.

9.

Inter-subject variability in human atrial action potential in sinus rhythm versus chronic atrial fibrillation.

Sánchez C, Bueno-Orovio A, Wettwer E, Loose S, Simon J, Ravens U, Pueyo E, Rodriguez B.

PLoS One. 2014 Aug 26;9(8):e105897. doi: 10.1371/journal.pone.0105897. eCollection 2014.

10.

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW; ACC/AHA Task Force Members.

Circulation. 2014 Dec 2;130(23):e199-267. doi: 10.1161/CIR.0000000000000041. Epub 2014 Mar 28. No abstract available. Erratum in: Circulation. 2014 Dec 2;130(23):e272-4.

11.

Atrial fibrillation.

Munger TM, Wu LQ, Shen WK.

J Biomed Res. 2014 Jan;28(1):1-17. doi: 10.7555/JBR.28.20130191. Epub 2013 Dec 28. Review.

12.

Impact of controlling atrial fibrillation on outcomes relevant to the patient: focus on dronedarone.

Chahal CA, Ali O, Hunter RJ, Schilling RJ.

Patient Relat Outcome Meas. 2012;3:95-103. doi: 10.2147/PROM.S16678. Epub 2012 Dec 19.

13.

Is dronedarone really safer than amiodarone?

Shah SM, Shah M.

Indian J Pharmacol. 2012 Nov-Dec;44(6):805-6. doi: 10.4103/0253-7613.103308. No abstract available.

14.

Antiarrhythmic therapy in atrial fibrillation: indications, guidelines, and safety.

Barekatain A, Razavi M.

Tex Heart Inst J. 2012;39(4):532-4. Review. No abstract available.

15.

Current issues in atrial fibrillation.

Khaykin Y, Shamiss Y.

ISRN Cardiol. 2012;2012:376071. doi: 10.5402/2012/376071. Epub 2012 Jun 21.

16.

Addressing the management of atrial fibrillation - a systematic review of the role of dronedarone.

Podda GM, Casazza G, Casella F, Dipaola F, Scannella E, Tagliabue L.

Int J Gen Med. 2012;5:465-78. doi: 10.2147/IJGM.S16674. Epub 2012 May 28.

17.

Pharmacotherapy in Medicare beneficiaries with atrial fibrillation.

Piccini JP, Mi X, DeWald TA, Go AS, Hernandez AF, Curtis LH.

Heart Rhythm. 2012 Sep;9(9):1403-8. doi: 10.1016/j.hrthm.2012.04.031. Epub 2012 Apr 24.

18.

Cost considerations in the management of atrial fibrillation - impact of dronedarone.

Khaykin Y, Shamiss Y.

Clinicoecon Outcomes Res. 2012;4:67-78. doi: 10.2147/CEOR.S16675. Epub 2012 Mar 6.

19.

Managing atrial fibrillation in the elderly: critical appraisal of dronedarone.

Trigo P, Fischer GW.

Clin Interv Aging. 2012;7:1-13. doi: 10.2147/CIA.S16677. Epub 2011 Dec 30. Review.

20.

The Na+/K+ pump is an important modulator of refractoriness and rotor dynamics in human atrial tissue.

Sánchez C, Corrias A, Bueno-Orovio A, Davies M, Swinton J, Jacobson I, Laguna P, Pueyo E, Rodríguez B.

Am J Physiol Heart Circ Physiol. 2012 Mar 1;302(5):H1146-59. doi: 10.1152/ajpheart.00668.2011. Epub 2011 Dec 23.

Supplemental Content

Support Center